ABOUT
What was the Focus for 2024?
Building on 13 years with the injectable combination device community, we have witnessed evolution from pre-filled syringes, to autoinjectors, to connected devices making their own mark on the field.
Recognizing the industry’s focus on formulation-device compatibility, patient-centric design, high-volume drugs and a new era in connected and digital health, we are faced with new challenges to tackle. In 2024, the 14th Injectables Summit was your only forum supported streamlining biopharma’s injectable device development from drug-product device integration to verification and validation, through technical content to take actionable insights back with you.
Back with a defined technical scope, in 2024 we brought you fresh insights on:
Increased content on complex formulation and device compatibility from device integration perspective upfront to accelerate timelines and streamline development, even before phase 1
Increased insights on high volume and high concentration injectables and devices leaning towards at home self-administration
Novel technologies: understanding AI’s role in accelerating combination product development through automation and modelling data, and how these plays into regulations
3 Days, 2 Workshops, 21 Speakers: with expert speakers sharing their insights across 3 days of in-depth content, you can leave no stone unturned and get all your questions answered from device type to patient population
Built with industry experts, we were excited to bring this summit to you last October, with unmissable content highlights from Novo Nordisk, GSK, Pfizer and more industry giants. Can you afford to miss out?
‘’A good opportunity to learn from other contributors in the industry, see some of the new products being developed, as well as to compare notes on challenges or evolving approaches in the industry.’’
Previous Attendee, Eli Lilly & Company
‘’Array of topics and diversity of attendees' expertise and the size encouraged discussion.’’
Previous Attendee, Enable Injections